Thomas Patrick Kelly

Insider Reports History

Entity
Individual
Location
C/O Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham, MA
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Patrick Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Deciphera Pharmaceuticals, Inc. Chief Financial Officer Common Stock 0 $0 $15.62 Jun 11, 2024 Direct
Deciphera Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 $0 $10.58 Jun 11, 2024 Direct

Insider Reports Filed by Thomas Patrick Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NA Deciphera Pharmaceuticals, Inc. Jun 11, 2024 10 $0 4 Jun 11, 2024 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Feb 15, 2024 3 -$47K 4 Feb 20, 2024 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Jan 16, 2024 1 -$35.2K 4 Jan 18, 2024 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Dec 12, 2023 2 -$42.9K 4 Dec 14, 2023 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Oct 28, 2023 2 -$27.8K 4 Oct 31, 2023 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Jun 16, 2023 1 -$23.8K 4 Jun 21, 2023 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Feb 15, 2023 3 -$20.7K 4 Feb 17, 2023 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Jan 17, 2023 1 -$51K 4 Jan 19, 2023 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Jun 16, 2022 1 -$19K 4 Jun 21, 2022 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Feb 16, 2022 1 -$12.4K 4 Feb 18, 2022 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Jan 18, 2022 2 $0 4 Jan 20, 2022 Chief Financial Officer
DCPH Deciphera Pharmaceuticals, Inc. Dec 15, 2021 2 $0 4 Dec 17, 2021 Chief Financial Officer